Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Net Margin: 2009-2025

Historic Net Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -23.50%.

  • Cumberland Pharmaceuticals' Net Margin fell 659.00% to -23.50% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.09%, marking a year-over-year increase of 2139.00%. This contributed to the annual value of -17.02% for FY2024, which is 101.00% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Net Margin of -23.50% as of Q3 2025, which was down 246.46% from -6.78% recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Net Margin's 5-year high stood at 10.66% during Q1 2025, with a 5-year trough of -67.38% in Q4 2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Net Margin value was -11.20% (recorded in 2024), while the average stood at -14.23%.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Net Margin tumbled by 4,042bps in 2023 and then spiked by 4,916bps in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' Net Margin (Quarterly) stood at 6.05% in 2021, then tumbled by 3,301bps to -26.96% in 2022, then plummeted by 4,042bps to -67.38% in 2023, then surged by 4,916bps to -18.22% in 2024, then crashed by 659bps to -23.50% in 2025.
  • Its Net Margin stands at -23.50% for Q3 2025, versus -6.78% for Q2 2025 and 10.66% for Q1 2025.